Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.24B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$552M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$535M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$471M |
| 5 |
Palo Alto Networks
PANW
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.11B |
| 2 |
Apple
AAPL
|
+$2.02B |
| 3 |
Microsoft
MSFT
|
+$612M |
| 4 |
Amazon
AMZN
|
+$554M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.61% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.07% |
| 4 | Healthcare | 1.03% |
| 5 | Communication Services | 0.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7626
Kodak
KODK
$987M
| $177K | ﹤0.01% |
42,028
+18,460
| +78% | +$90.3K |
|
7627
CALL
NGL Energy Partners
NGL
$2.13B
| $177K | ﹤0.01% |
45,700
-23,500
| -34% | -$92.1K |
|
|
DVAX
7628
DELISTED
Dynavax Technologies
DVAX
| $177K | ﹤0.01% |
11,961
-133,879
| -92% | -$1.88M |
|
7629
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $176K | ﹤0.01% |
10,148
-16,271
| -62% | -$274K |
|
7630
The RealReal
REAL
$1.44B
| $176K | ﹤0.01% |
83,515
-215,395
| -72% | -$525K |
|
|
FBZ
7631
DELISTED
First Trust Brazil AlphaDEX Fund
FBZ
| $176K | ﹤0.01% |
17,358
-65,680
| -79% | -$706K |
|
7632
P3 Health Partners
PIII
$41.1M
| $175K | ﹤0.01% |
2,385
+1,954
| +453% | +$203K |
|
7633
CALL
Vroom Inc
VRM
$51.5M
| $175K | ﹤0.01% |
1,956
+1,288
| +193% | +$162K |
|
|
DVAX
7634
PUT
DELISTED
Dynavax Technologies
DVAX
| $174K | ﹤0.01% |
11,800
-90,600
| -88% | -$1.27M |
|
7635
Adaptive Biotechnologies
ADPT
$4.04B
| $174K | ﹤0.01% |
31,966
-47,924
| -60% | -$317K |
|
7636
Genius Sports
GENI
$2.16B
| $174K | ﹤0.01% |
32,595
-43,208
| -57% | -$286K |
|
|
MTTR
7637
CALL
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $173K | ﹤0.01% |
79,800
-176,000
| -69% | -$493K |
|
7638
BBVA Argentina
BBAR
$3.36B
| $173K | ﹤0.01% |
+41,641
| New | +$223K |
|
7639
PUT
TripAdvisor
TRIP
$1.28B
| $172K | ﹤0.01% |
10,400
-3,700
| -26% | -$60.4K |
|
7640
Empire State Realty Trust
ESRT
$802M
| $172K | ﹤0.01% |
21,406
-326,113
| -94% | -$2.72M |
|
|
DHC
7641
CALL
Diversified Healthcare Trust
DHC
$1.98B
| $171K | ﹤0.01% |
88,200
-132,300
| -60% | -$335K |
|
7642
Fulcrum Therapeutics
FULC
$282M
| $171K | ﹤0.01% |
38,501
-27,792
| -42% | -$121K |
|
|
CVAC
7643
DELISTED
CureVac
CVAC
| $171K | ﹤0.01% |
25,011
-20,976
| -46% | -$185K |
|
7644
KLX Energy Services
KLXE
$31.8M
| $170K | ﹤0.01% |
+14,346
| New | +$160K |
|
7645
CALL
Lifecore Biomedical
LFCR
$183M
| $170K | ﹤0.01% |
22,500
-7,700
| -25% | -$70.4K |
|
7646
Lantronix
LTRX
$264M
| $169K | ﹤0.01% |
38,025
+12,926
| +52% | +$56.7K |
|
7647
NovaGold Resources
NG
$3.37B
| $169K | ﹤0.01% |
44,010
-69,425
| -61% | -$292K |
|
7648
Nuveen Preferred & Income Opportunities Fund
JPC
$2.91B
| $169K | ﹤0.01% |
+26,656
| New | +$172K |
|
|
NBP
7649
NovaBridge Biosciences American Depositary Shares
NBP
$213M
| $168K | ﹤0.01% |
+127,241
| New | +$279K |
|
7650
PUT
Pagaya Technologies
PGY
$1.77B
| $168K | ﹤0.01% |
+8,850
| New | +$215K |
|
Similar funds
Jane Street's Q3 2023 Portfolio in Review
As of Q3 2023, Jane Street held 9,820 positions worth $309B, up 4.1% from $297B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jane Street deployed $28.2B of net new capital in Q3 2023, opening 1,242 new positions and adding to 3,523 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 11,152,855 shares worth $531M.
By sector, the portfolio is most concentrated in Technology at 2.6% of assets, down from 4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Tesla, an estimated $2.11B trimmed.
- Jane Street's largest Q3 2023 buy was iShares Core MSCI Emerging Markets ETF: 11,152,855 shares worth $531M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $6.24B increase.
- Jane Street's biggest Q3 2023 reduction was Tesla, cutting an estimated $2.11B.
- Jane Street fully exited iShares Silver Trust in Q3 2023, selling an estimated $130M.
- Jane Street's ten largest holdings make up 40% of its $309B portfolio in Q3 2023.
- Jane Street opened 1,242 new positions and closed 1,288 in Q3 2023.
- Jane Street's portfolio value rose 4.1% quarter-over-quarter to $309B.
Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.